Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimization of Ocular Surface Microbiome Sampling (EPSO)
NCT04193774Completed
- Sponsor
- UZ Leuven
- Start
- Aug 2019
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of oxybuprocaine (2 arms), sponsored by UZ Leuven. Primary endpoints: Difference in richness of the microbial flora measured as operational taxonomic units at 5 minutes and Difference in evenness of distribution of the microbial flora measured as operational taxonomic units at 5 minutes. Started Aug 2019; status: completed.
02
Drugs
oxybuprocaine
Beyond the preview
Go deeper on NCT04193774.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04193774.